Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel in New York City. Talphera's management will be available for one-on-one meetings during the conference.
The company's presentation will be accessible on-demand starting September 9 at 7:00 AM ET. Interested parties can view the presentation through a provided link or by visiting the Investors section of Talphera's website at www.talphera.com. The webcast link can be found in the Investors/News & Events/Upcoming Events section.
Talphera (Nasdaq: TLPH), una società farmaceutica specializzata, ha annunciato la sua partecipazione alla 26ª Conferenza Annuale Globale sugli Investimenti H.C. Wainwright. L'evento si terrà dal 9 all'11 settembre 2024, presso il Lotte New York Palace Hotel a New York. Il management di Talphera sarà disponibile per incontri individuali durante la conferenza.
La presentazione dell'azienda sarà accessibile on-demand a partire dal 9 settembre alle 7:00 ET. Le parti interessate possono visualizzare la presentazione tramite un link fornito o visitando la sezione Investitori del sito web di Talphera all'indirizzo www.talphera.com. Il link per il webcast sarà disponibile nella sezione Investitori/Notizie & Eventi/Eventi Futuri.
Talphera (Nasdaq: TLPH), una compañía farmacéutica especializada, anunció su participación en la 26ª Conferencia Anual Global de Inversiones H.C. Wainwright. El evento está programado para del 9 al 11 de septiembre de 2024, en el Lotte New York Palace Hotel en la ciudad de Nueva York. La dirección de Talphera estará disponible para reuniones uno a uno durante la conferencia.
La presentación de la compañía estará disponible a la carta a partir del 9 de septiembre a las 7:00 AM ET. Las partes interesadas pueden ver la presentación a través de un enlace proporcionado o visitando la sección de Inversores en el sitio web de Talphera en www.talphera.com. El enlace del webcast se puede encontrar en la sección Inversores/Noticias y Eventos/Eventos Futuros.
탈페라 (Nasdaq: TLPH), 전문 제약 회사,는 H.C. 웨인라이트 제26회 연례 글로벌 투자 회의에 참여한다고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 뉴욕시의 롯데 뉴욕 팰리스 호텔에서 개최됩니다. 탈페라 경영진은 회의 중 일대일 회의를 위해 참석할 예정입니다.
회사의 프레젠테이션은 9월 9일 오전 7:00 ET부터 주문형으로 제공됩니다. 관심 있는 분들은 제공된 링크를 통해 프레젠테이션을 보거나 탈페라 웹사이트의 투자자 섹션(www.talphera.com)을 방문하여 확인할 수 있습니다. 웹캐스트 링크는 투자자/뉴스 & 이벤트/예정된 이벤트 섹션에서 확인할 수 있습니다.
Talphera (Nasdaq: TLPH), une entreprise pharmaceutique spécialisée, a annoncé sa participation à la 26e Conférence Annuelle Mondiale sur les Investissements H.C. Wainwright. L'événement est prévu du 9 au 11 septembre 2024, à l'Hôtel Lotte New York Palace à New York. La direction de Talphera sera disponible pour des réunions individuelles pendant la conférence.
La présentation de l'entreprise sera accessible à la demande à partir du 9 septembre à 7h00 ET. Les parties intéressées peuvent visionner la présentation via un lien fourni ou en visitant la section Investisseurs du site de Talphera à l'adresse www.talphera.com. Le lien du webcast se trouve dans la section Investisseurs/Actualités & Événements/Événements à venir.
Talphera (Nasdaq: TLPH), ein Spezialpharmaunternehmen, kündigte seine Teilnahme an der 26. jährlichen globalen Investmentkonferenz von H.C. Wainwright an. Die Veranstaltung ist für 9. bis 11. September 2024 im Lotte New York Palace Hotel in New York City geplant. Das Management von Talphera wird während der Konferenz für Einzelgespräche zur Verfügung stehen.
Die Präsentation des Unternehmens wird ab dem 9. September um 7:00 Uhr ET auf Abruf verfügbar sein. Interessierte Parteien können die Präsentation über einen bereitgestellten Link oder durch den Besuch des Investorenbereichs auf der Website von Talphera unter www.talphera.com ansehen. Der Link zur Webcast findet sich im Abschnitt Investoren/News & Events/Bevorstehende Veranstaltungen.
- None.
- None.
The conference is being held on September 9-11, 2024, at the Lotte New York Palace Hotel in
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-the-hc-wainwright-26th-annual-global-investment-conference-302239931.html
SOURCE Talphera, Inc.
FAQ
When is Talphera (TLPH) participating in the H.C. Wainwright Global Investment Conference?
Where can I watch Talphera's (TLPH) presentation from the H.C. Wainwright conference?
Will Talphera (TLPH) be offering one-on-one meetings at the H.C. Wainwright conference?
What is the venue for the H.C. Wainwright conference where Talphera (TLPH) is participating?
